Associated Banc Corp trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 59,478 shares of the healthcare conglomerate’s stock after selling 879 shares during the period. UnitedHealth Group accounts for about 1.0% of Associated Banc Corp’s holdings, making the stock its 26th biggest holding. Associated Banc Corp’s holdings in UnitedHealth Group were worth $34,776,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently modified their holdings of UNH. Bank of New York Mellon Corp boosted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after buying an additional 35,533 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares during the last quarter. Ameriprise Financial Inc. increased its stake in UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after purchasing an additional 21,149 shares during the last quarter. Finally, Fisher Asset Management LLC grew its position in shares of UnitedHealth Group by 3.5% during the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock valued at $1,869,320,000 after buying an additional 107,097 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
Shares of UNH traded up $9.45 during trading hours on Monday, reaching $600.32. 334,306 shares of the company traded hands, compared to its average volume of 3,855,879. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market cap of $552.46 billion, a P/E ratio of 38.49, a price-to-earnings-growth ratio of 1.73 and a beta of 0.58. The stock’s fifty day moving average is $582.63 and its 200 day moving average is $553.30.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on UNH. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Finally, KeyCorp began coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $615.53.
Get Our Latest Analysis on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Dividend Payout Ratio Calculator
- Discover the 3 Best Performing Stocks That Went Public in 2024
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Strategic ETFs for Bearish Investors Post-Election
- What is the Nikkei 225 index?
- Super Micro’s Stock Price Is Ready to Rebound After Market Reset
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.